Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is -22.18% vs 146.48% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 13.71% vs 121.47% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 7.29% vs 18.52% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Jagsonpal Pharma With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
287.23
177.58
109.65
61.75%
Other Operating Income
0.00
0.00
0.00
Total Operating income
287.23
177.58
109.65
61.75%
Raw Material Cost
16.11
95.47
-79.36
-83.13%
Purchase of Finished goods
89.19
0.00
89.19
(Increase) / Decrease In Stocks
-0.93
-13.20
12.27
92.95%
Employee Cost
70.74
31.65
39.09
123.51%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
-0.01
0.02
200.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
54.04
13.99
40.05
286.28%
Total Expenditure (Excl Depreciation)
229.16
127.90
101.26
79.17%
Operating Profit (PBDIT) excl Other Income
58.07
49.68
8.39
16.89%
Other Income
12.00
1.31
10.69
816.03%
Operating Profit (PBDIT)
70.07
50.99
19.08
37.42%
Interest
1.03
8.54
-7.51
-87.94%
Exceptional Items
-2.08
-0.05
-2.03
-4,060.00%
Gross Profit (PBDT)
66.96
42.40
24.56
57.92%
Depreciation
9.44
20.88
-11.44
-54.79%
Profit Before Tax
57.52
21.53
35.99
167.16%
Tax
14.44
4.03
10.41
258.31%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
43.08
17.50
25.58
146.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
43.08
17.50
25.58
146.17%
Equity Capital
13.39
21.95
-8.56
-39.00%
Face Value
2.00
10.00
0.00
Reserves
262.78
260.73
2.05
0.79%
Earnings per share (EPS)
6.43
7.97
-1.54
-19.32%
Diluted Earnings per share
6.31
7.95
-1.64
-20.63%
Operating Profit Margin (Excl OI)
20.22%
27.98%
0.00
-7.76%
Gross Profit Margin
23.31%
23.88%
0.00
-0.57%
PAT Margin
15.00%
9.85%
0.00
5.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 287.23 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.89% vs 28.76% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 43.08 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -22.18% vs 146.48% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 58.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.71% vs 121.47% in Mar 2025
Annual - Interest
Interest 1.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.29% vs 18.52% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.22%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
